Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.
iRARC adoption is slow but persistent in bladder cancer
"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.
What should the adult urologist know about pediatric urologic cancers?
FDA grants de novo authorization to ArteraAI Prostate
FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea
Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD